Results 21 to 30 of about 14,693 (147)

Rare primary peritoneal mucinous adenocarcinoma in a 69‐year‐old man

open access: yesClinical Case Reports, 2021
Primary peritoneal mucinous adenocarcinoma is rare in men. The low‐grade tumor consisted of mucin‐producing columnar cells with minimal nuclear atypia. Relationship to pseudomyxoma peritonei and disseminated peritoneal adenomucinosis is discussed.
Fumiko Satoh, Yutaka Tsutusmi
doaj   +1 more source

The management of pseudomyxoma peritonei [PDF]

open access: yesCancer, 1990
The management of nine patients with pseudomyxoma peritonei was reviewed. Aggressive surgical resection of tumor is the standard of treatment, with many patients requiring multiple laparotomies. Chemotherapy, including the use of cisplatin is not effective. Long-term nutritional support provides a better quality of survival for select patients.
W J, Mann   +3 more
openaire   +2 more sources

Rapid recurrence of a ruptured mucinous borderline ovarian tumor harboring K-RAS mutation followed by progression into anaplastic carcinoma with TP53 mutation

open access: yesHeliyon, 2022
We describe the case of a young patient with a borderline mucinous ovarian tumor that progressed into ipsilateral ovarian anaplastic carcinoma in only 3 months with metastasis to the contralateral ovary and extensive spread in the pelvic and abdominal ...
Yang Yang   +3 more
doaj   +1 more source

A case of Pseudomyxoma Peritonei of an unexpected origin

open access: yesDiagnostic Pathology, 2021
Background Pseudomyxoma peritonei (PMP) is a complex and partially understood disease defined by mucin deposits in the peritoneal cavity, mostly of appendiceal origin caused by the rupture of a mucocele often containing Low or High grade Appendiceal ...
Marie Csanyi-Bastien   +3 more
doaj   +1 more source

Pseudomyxoma Peritonei in a Patient with History of Breast Cancer

open access: yesThe Korean Journal of Gastroenterology, 2016
Pseudomyxoma peritonei is a very rare condition, and even rarer in patients with history of cancer. A 70-year old woman with a history of breast cancer was admitted with abdominal pain and distention.
Tae Seob Jung   +6 more
doaj   +1 more source

CHALLENGES IN CHOICE OF THE TREATMENT STRATEGY FOR PATIENTS WITH RECURRENT PSEUDOMYXOMA PERITONEI

open access: yesСибирский онкологический журнал, 2019
Pseudomixoma peritonei is a rare type of peritoneal carcinomatosis accompanied by accumulation of mucus and high recurrence rate and in some cases complicated with intestinal obstruction.
A. G. Abdullaev   +2 more
doaj   +1 more source

Natural History from Appendiceal Mucocele to Jelly Belly

open access: yesDiagnostics
Mucocele of the appendix and pseudomyxoma peritonei are rare diseases. The clinical findings are nonspecific in the early stages of the disease. The sequelae of appendiceal mucocele, its perforation, and extensive peritoneal involvement via pseudomyxoma ...
David Hoskovec   +7 more
doaj   +1 more source

Pseudomyxoma peritonei de origem appendicular Pseudomyxoma peritonei ex processu vermiformi

open access: yesMemorias do Instituto Oswaldo Cruz, 1937
Os autores descrevem um caso de pseudomyxoma do peritoneo, originario do appendice ileo-cecal, em individuo do sexo masculino, de 58 anos de edade.
A. Penna de Azevedo   +1 more
doaj   +1 more source

Cytoreduction and Hyperthermic Intrathoracic Chemotherapy for Metastatic Pseudomyxoma Peritonei

open access: yesAnnals of Thoracic Surgery Short Reports
Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ...
Luke J. Matzek, MD   +7 more
doaj   +1 more source

Germline and somatic genetic alterations in two first‐degree relatives with appendiceal low‐grade mucinous carcinoma peritonei

open access: yesClinical Case Reports, 2020
Comparing genetic mutations of first‐degree relatives with appendiceal pseudomyxoma peritonei may explain clinical outcomes and disease pathogenesis. Molecular profiling of mucinous tumors may identify improved treatments to traditional chemotherapy.
Mary Caitlin King   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy